- Home
- RLAY vs DDL Comparison
RLAY vs DDL Comparison
Compare RLAY & DDL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RLAY
- DDL
- Stock Information
- Founded
- RLAY 2015
- DDL 2014
- Country
- RLAY United States
- DDL China
- Employees
- RLAY N/A
- DDL N/A
- Industry
- RLAY Biotechnology: Biological Products (No Diagnostic Substances)
- DDL Catalog/Specialty Distribution
- Sector
- RLAY Health Care
- DDL Consumer Discretionary
- Exchange
- RLAY Nasdaq
- DDL Nasdaq
- Market Cap
- RLAY 620.4M
- DDL 666.1M
- IPO Year
- RLAY 2020
- DDL 2021
- Fundamental
- Price
- RLAY $2.62
- DDL $2.71
- Analyst Decision
- RLAY Strong Buy
- DDL
- Analyst Count
- RLAY 10
- DDL 0
- Target Price
- RLAY $19.33
- DDL N/A
- AVG Volume (30 Days)
- RLAY 2.5M
- DDL 828.3K
- Earning Date
- RLAY 05-01-2025
- DDL 03-06-2025
- Dividend Yield
- RLAY N/A
- DDL N/A
- EPS Growth
- RLAY N/A
- DDL N/A
- EPS
- RLAY N/A
- DDL 0.13
- Revenue
- RLAY $10,007,000.00
- DDL $3,158,412,712.00
- Revenue This Year
- RLAY N/A
- DDL $17.17
- Revenue Next Year
- RLAY $544.28
- DDL $14.00
- P/E Ratio
- RLAY N/A
- DDL $21.52
- Revenue Growth
- RLAY N/A
- DDL 4.61
- 52 Week Low
- RLAY $2.45
- DDL $1.08
- 52 Week High
- RLAY $10.72
- DDL $4.79
- Technical
- Relative Strength Index (RSI)
- RLAY 32.07
- DDL 34.70
- Support Level
- RLAY $3.05
- DDL $2.79
- Resistance Level
- RLAY $3.08
- DDL $2.95
- Average True Range (ATR)
- RLAY 0.25
- DDL 0.14
- MACD
- RLAY -0.04
- DDL -0.02
- Stochastic Oscillator
- RLAY 11.64
- DDL 12.61
About RLAY Relay Therapeutics Inc.
Relay Therapeutics Inc is a clinical-stage precision medicine company transforming the drug discovery process by combining leading-edge computational and experimental technologies with the goal of bringing life-changing therapies to patients. the Dynamo platform integrates an array of leading-edge computational and experimental approaches designed to drug-protein targets that have previously been intractable or inadequately addressed. The company is advancing a pipeline of medicine candidates to address targets in precision oncology and genetic disease, including product candidates, RLY-4008, RLY-2608, and GDC-1971 (formerly known as RLY-1971).
About DDL Dingdong (Cayman) Limited (each two representing three)
Dingdong (Cayman) Ltd is the fastest growing on-demand e-commerce company in China. The company directly provides users and households with fresh produce, meat and seafood, and other daily necessities through a convenient shopping experience supported by an extensive self-operated frontline fulfillment grid. It recognizes revenues from product sales of fresh groceries and other daily necessities through Dingdong Fresh APP and mini-programs and membership services.